Hostname: page-component-cb9f654ff-qc88w Total loading time: 0 Render date: 2025-08-22T12:04:06.786Z Has data issue: false hasContentIssue false
  • English
  • Français

Surgical pulmonary valve insertion*

Published online by Cambridge University Press:  09 January 2014

Cheul Lee ,
Chang-Ha Lee  and
Jae Gun Kwak
Cheul Lee*
Affiliation:
Department of Thoracic and Cardiovascular Surgery, Cardiovascular Center, Sejong General Hospital, Bucheon, Republic of Korea
Chang-Ha Lee
Affiliation:
Department of Thoracic and Cardiovascular Surgery, Cardiovascular Center, Sejong General Hospital, Bucheon, Republic of Korea
Jae Gun Kwak
Affiliation:
Department of Thoracic and Cardiovascular Surgery, Cardiovascular Center, Sejong General Hospital, Bucheon, Republic of Korea
*
Correspondence to: Dr C. Lee, MD, PhD, Department of Thoracic and Cardiovascular Surgery, Cardiovascular Center, Sejong General Hospital, 91-121 Sosa Bon 2-dong, Sosa-gu, Bucheon, Gyeonggi-do 422-711, Republic of Korea. Tel: +82 32 340 1451; Fax: +82 32 340 1236; E-mail: tscheul@hanmail.net
Get access Rights & Permissions [Opens in a new window]

Abstract

Pulmonary valve replacement is being performed with increasing frequency in patients with various congenital heart diseases. Chronic pulmonary regurgitation after repair of tetralogy of Fallot is a typical situation that requires pulmonary valve replacement. Chronic pulmonary regurgitation after repair of tetralogy of Fallot can lead to right ventricular dilatation, biventricular dysfunction, heart failure symptoms, arrhythmias, and sudden death. Although pulmonary valve replacement can lead to improvement in functional class and a substantial decrease or normalisation of right ventricular volumes, the optimal timing of pulmonary valve replacement in patients with chronic pulmonary regurgitation is still unknown. There are several options for surgical pulmonary valve replacement. However, no ideal pulmonary valve substitute exists currently and most of the surgically implanted pulmonary valves will eventually require re-replacement. This article will review options and timing of surgical pulmonary valve insertion in patients with chronic pulmonary regurgitation after repair of tetralogy of Fallot.

Keywords

Pulmonary regurgitationpulmonary valve replacementsurgerytetralogy of Fallot

Information

Type
Original Article
Information
Cardiology in the Young , Volume 23 , Issue 6: HeartWeek 2013 , December 2013 , pp. 915 - 920
Copyright
Copyright © Cambridge University Press 2013 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

Footnotes

*

Presented at “The Birth of Heart Surgery: Lessons Learned from Tetralogy – Past, Present and Future” Dinner Symposium Sponsored by Johns Hopkins Medicine and All Children's Hospital, Thursday, February 21, 2013, at The Sixth World Congress of Paediatric Cardiology and Cardiac Surgery, Cape Town International Convention Centre, Cape Town, South Africa, February 17–22, 2013. A video of this presentation can be viewed at the following hyperlink: [http://www.allkids.org/wcpccs].

References

1.Murphy, JG, Gersh, BJ, Mair, DD, et al. Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot. N Engl J Med 1993; 329: 593–599.Google Scholar
2.Therrien, J, Marx, GR, Gatzoulis, MA. Late problems in tetralogy of Fallot – recognition, management, and prevention. Cardiol Clin 2002; 20: 395–404.CrossRefGoogle ScholarPubMed
3.Gatzoulis, MA, Balaji, S, Webber, SA, et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet 2000; 356: 975–981.CrossRefGoogle ScholarPubMed
4.Geva, T, Sandweiss, BM, Gauvreau, K, Lock, JE, Powell, AJ. Factors associated with impaired clinical status in long-term survivors of tetralogy of Fallot repair evaluated by magnetic resonance imaging. J Am Coll Cardiol 2004; 43: 1068–1074.Google Scholar
5.Bouzas, B, Kilner, PJ, Gatzoulis, MA. Pulmonary regurgitation: not a benign lesion. Eur Heart J 2005; 26: 433–439.Google Scholar
6.Al Habib, HF, Jacobs, JP, Mavroudis, C, et al. Contemporary patterns of management of tetralogy of Fallot: data from the Society of Thoracic Surgeons Database. Ann Thorac Surg 2010; 90: 813–820.CrossRefGoogle ScholarPubMed
7.Sarris, GE, Comas, JV, Tobota, Z, Maruszewski, B. Results of reparative surgery for tetralogy of Fallot: data from the European Association for Cardio-Thoracic Surgery Congenital Database. Eur J Cardiothorac Surg 2012; 42: 766–774.CrossRefGoogle ScholarPubMed
8.Geva, T, Gauvreau, K, Powell, AJ, et al. Randomized trial of pulmonary valve replacement with and without right ventricular remodeling surgery. Circulation 2010; 122 (Suppl 11): S201–S208.CrossRefGoogle ScholarPubMed
9.Dave, HH, Buechel, ER, Dodge-Khatami, A, et al. Early insertion of a pulmonary valve for chronic regurgitation helps restoration of ventricular dimensions. Ann Thorac Surg 2005; 80: 1615–1621.Google Scholar
10.Oosterhof, T, van Straten, A, Vliegen, HW, et al. Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance. Circulation 2007; 116: 545–551.Google Scholar
11.Frigiola, A, Tsang, V, Bull, C, et al. Biventricular response after pulmonary valve replacement for right ventricular outflow tract dysfunction: is age a predictor of outcome? Circulation 2008; 118 (Suppl 14): S182–S190.Google Scholar
12.Lim, C, Lee, JY, Kim, WH, et al. Early replacement of pulmonary valve after repair of tetralogy: is it really beneficial? Eur J Cardiothorac Surg 2004; 25: 728–734.Google Scholar
13.Scherptong, RW, Hazekamp, MG, Mulder, BJ, et al. Follow-up after pulmonary valve replacement in adults with tetralogy of Fallot: association between QRS duration and outcome. J Am Coll Cardiol 2010; 56: 1486–1492.CrossRefGoogle ScholarPubMed
14.Ghez, O, Tsang, VT, Frigiola, A, et al. Right ventricular outflow tract reconstruction for pulmonary regurgitation after repair of tetralogy of Fallot. Preliminary results. Eur J Cardiothorac Surg 2007; 31: 654–658.CrossRefGoogle ScholarPubMed
15.Therrien, J, Provost, Y, Merchant, N, Williams, W, Colman, J, Webb, G. Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair. Am J Cardiol 2005; 95: 779–782.Google Scholar
16.Frigiola, A, Giamberti, A, Chessa, M, et al. Right ventricular restoration during pulmonary valve implantation in adults with congenital heart disease. Eur J Cardiothorac Surg 2006; 29 (Suppl 1): S279–S285.Google Scholar
17.Harrild, DM, Berul, CI, Cecchin, F, et al. Pulmonary valve replacement in tetralogy of Fallot: impact on survival and ventricular tachycardia. Circulation 2009; 119: 445–451.Google Scholar
18.Therrien, J, Siu, SC, Harris, L, et al. Impact of pulmonary valve replacement on arrhythmia propensity late after repair of tetralogy of Fallot. Circulation 2001; 103: 2489–2494.Google Scholar
19.Doughan, AR, McConnell, ME, Lyle, TA, Book, WM. Effects of pulmonary valve replacement on QRS duration and right ventricular cavity size late after repair of right ventricular outflow tract obstruction. Am J Cardiol 2005; 95: 1511–1514.CrossRefGoogle ScholarPubMed
20.Gengsakul, A, Harris, L, Bradley, TJ, et al. The impact of pulmonary valve replacement after tetralogy of Fallot repair: a matched comparison. Eur J Cardiothorac Surg 2007; 32: 462–468.Google Scholar
21.Cheung, EW, Wong, WH, Cheung, YF. Meta-analysis of pulmonary valve replacement after operative repair of tetralogy of Fallot. Am J Cardiol 2010; 106: 552–557.Google Scholar
22.Dos, L, Dadashev, A, Tanous, D, et al. Pulmonary valve replacement in repaired tetralogy of Fallot: determinants of early postoperative adverse outcomes. J Thorac Cardiovasc Surg 2009; 138: 553–559.Google Scholar
23.Borger, MA, Ivanov, J, Armstrong, S, Christie-Hrybinsky, D, Feindel, CM, David, TE. Twenty-year results of the Hancock II bioprosthesis. J Heart Valve Dis 2006; 15: 49–55.Google Scholar
24.McClure, RS, Narayanasamy, N, Wiegerinck, E, et al. Late outcomes for aortic valve replacement with the Carpentier-Edwards pericardial bioprosthesis: up to 17-year follow-up in 1000 patients. Ann Thorac Surg 2010; 89: 1410–1416.Google Scholar
25.Zubairi, R, Malik, S, Jaquiss, RD, Imamura, M, Gossett, J, Morrow, WR. Risk factors for prosthesis failure in pulmonary valve replacement. Ann Thorac Surg 2011; 91: 561–565.Google Scholar
26.Chen, PC, Sager, MS, Zurakowski, D, et al. Younger age and valve oversizing are predictors of structural valve deterioration after pulmonary valve replacement in patients with tetralogy of Fallot. J Thorac Cardiovasc Surg 2012; 143: 352–360.Google Scholar
27.Konakci, KZ, Bohle, B, Blumer, R, et al. Alpha-Gal on bioprostheses: xenograft immune response in cardiac surgery. Eur J Clin Invest 2005; 35: 17–23.Google Scholar
28.Manji, RA, Zhu, LF, Nijjar, NK, et al. Glutaraldehyde-fixed bioprosthetic heart valve conduits calcify and fail from xenograft rejection. Circulation 2006; 114: 318–327.Google Scholar
29.Lee, C, Ahn, H, Kim, SH, Choi, SY, Kim, YJ. Immune response to bovine pericardium implanted into α1,3-galactosyltransferase knockout mice: feasibility as an animal model for testing efficacy of anticalcification treatments of xenografts. Eur J Cardiothorac Surg 2012; 42: 164–172.Google Scholar
30.Lee, C, Park, CS, Lee, CH, et al. Durability of bioprosthetic valves in the pulmonary position: long-term follow-up of 181 implants in patients with congenital heart disease. J Thorac Cardiovasc Surg 2011; 142: 351–358.Google Scholar
31.Jang, WS, Kim, YJ, Choi, K, Lim, HG, Kim, WH, Lee, JR. Mid-term results of bioprosthetic pulmonary valve replacement in pulmonary regurgitation after tetralogy of Fallot repair. Eur J Cardiothorac Surg 2012; 42: e1–e8.Google Scholar
32.van de Woestijne, PC, Mokhles, MM, de Jong, PL, Witsenburg, M, Takkenberg, JJ, Bogers, AJ. Right ventricular outflow tract reconstruction with an allograft conduit in patients after tetralogy of Fallot correction: long-term follow-up. Ann Thorac Surg 2001; 92: 161–166.CrossRefGoogle Scholar
33.Oosterhof, T, Meijboom, FJ, Vliegen, HW, et al. Long-term follow-up of homograft function after pulmonary valve replacement in patients with tetralogy of Fallot. Eur Heart J 2006; 27: 1478–1484.Google Scholar
34.Shin, HJ, Kim, YH, Ko, JK, Park, IS, Seo, DM. Outcomes of mechanical valves in the pulmonic position in patients with congenital heart disease over a 20-year period. Ann Thorac Surg 2013; 95: 1367–1372.Google Scholar
35.Waterbolk, TW, Hoendermis, ES, den Hamer, IJ, Ebels, T. Pulmonary valve replacement with a mechanical prosthesis. Promising results of 28 procedures in patients with congenital heart disease. Eur J Cardiothorac Surg 2006; 30: 28–34.Google Scholar
36.Stulak, JM, Dearani, JA, Burkhart, HM, et al. The increasing use of mechanical pulmonary valve replacement over a 40-year period. Ann Thorac Surg 2010; 90: 2009–2015.Google Scholar
37.Quintessenza, JA, Jacobs, JP, Morell, VO, Giroud, JM, Boucek, RJ. Initial experience with a bicuspid polytetrafluoroethylene pulmonary valve in 41 children and adults: a new option for right ventricular outflow tract reconstruction. Ann Thorac Surg 2005; 79: 924–931.CrossRefGoogle ScholarPubMed
38.Quintessenza, JA. Polytetrafluoroethylene bicuspid pulmonary valve implantation. Oper Tech Thorac Cardiovasc Surg 2008; 13: 244–249.Google Scholar
39.Brown, JW, Ruzmetov, M, Vijay, P, Rodefeld, MD, Turrentine, MW. Right ventricular outflow tract reconstruction with a polytetrafluoroethylene monocusp valve: a twelve-year experience. J Thorac Cardiovasc Surg 2007; 133: 1336–1343.Google Scholar
40.Quintessenza, JA, Jacobs, JP, Chai, PJ, Morell, VO, Lindberg, H. Polytetrafluoroethylene bicuspid pulmonary valve implantation: experience with 126 patients. World J Pediatr Congenit Heart Surg 2010; 1: 20–27.Google Scholar
41.Lee, C, Lee, CH, Kwak, JG, et al. Bicuspid pulmonary valve implantation using polytetrafluoroethylene membrane: early results and assessment of the valve function by magnetic resonance imaging. Eur J Cardiothorac Surg 2013; 43: 468–472.Google Scholar
42.Warnes, CA, Williams, RG, Bashore, TM, et al. ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: Executive Summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines for the management of adults with congenital heart disease). Circulation 2008; 118: 2395–2451.Google Scholar
43.Lee, C, Kim, YM, Lee, CH, et al. Outcomes of pulmonary valve replacement in 170 patients with chronic pulmonary regurgitation after relief of right ventricular outflow tract obstruction: implications for optimal timing of pulmonary valve replacement. J Am Coll Cardiol 2012; 60: 1005–1014.Google Scholar
44.Geva, T. Repaired tetralogy of Fallot: the roles of cardiovascular magnetic resonance in evaluating pathophysiology and for pulmonary valve replacement decision support. J Cardiovasc Magn Reson 2011; 13: 9–32.Google Scholar
45.Henkens, IR, van Straten, A, Schalij, MJ, et al. Predicting outcome of pulmonary valve replacement in adult tetralogy of Fallot patients. Ann Thorac Surg 2007; 83: 907–911.CrossRefGoogle ScholarPubMed